Engineering of Amphiphilic Erlotinib Analogue as Novel Nanomedicine for Non-Small Cell Lung Cancer Therapy

作者
Mei Cong,Houjun Pang,Guangxing Xie,Feifei Li,Chunxiao Li,Hao Sun,Shaoyou Yang,Weidong Zhao
出处
期刊:International Journal of Nanomedicine [Dove Medical Press]
卷期号:Volume 18: 6367-6377 被引量:5
标识
DOI:10.2147/ijn.s432464
摘要

Purpose: Molecular targeted therapy is one of the most pivotal strategies in the treatment of non-small cell lung cancer, yet its curative effect is severely compromised by the poor aqueous solubility, low bioavailability and inadequate tumor accumulation of targeted agents. To enhance the efficacy of targeted agents, we demonstrate a novel self-assemble amphiphilic molecule based on erlotinib as an effective nanodrug for anti-cancer treatment. Methods: An amphiphilic molecule composed of hydrophobic erlotinib and hydrophilic biotin block was synthesized and characterized by nuclear magnetic resonance (NMR) as well as high-resolution mass spectrometry (HRMS). Then, nanoassemblies of the amphiphilic molecules are formulated by using nanoprecipitation method. Subsequently, the size, morphology, cell uptake, the anticancer activity and in vivo distribution of the newly constructed erlotinib nanodrug were systematically assessed by some methods, including transmission electron microscopy (TEM), dynamic light-scattering (DLS), flow cytometry, in vivo imaging system etc. Results: We developed a novel nanoformulation of erlotinib, which possesses a high drug loading of 45%. With the features of well-defined structure and small size, the obtained nanodrug could be effectively accumulated in tumor sites and rapidly internalized by cancer cells. Finally, the erlotinib-based nanoformulation showed considerably better anticancer activity compared to free erlotinib both in vitro and in vivo. Moreover, the nanodrug displayed great tolerability. Conclusion: Combining the advantageous features of both nanotechnology and self-assemble, this novel erlotinib nanomedicine constitutes a promising therapeutic candidate for cancer treatment. This study also underlines the potential use of amphiphilic molecule for improving drug efficacy as well as reducing drug toxicity, which could become a general strategy for the preparation of nanodrugs of active agents.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ref:rain完成签到 ,获得积分10
刚刚
杨淼发布了新的文献求助10
1秒前
饼大王完成签到,获得积分10
2秒前
3秒前
3秒前
一切顺利发布了新的文献求助10
3秒前
HY完成签到,获得积分10
3秒前
Gyqqqq发布了新的文献求助10
3秒前
inoo完成签到 ,获得积分10
4秒前
4秒前
5秒前
搜集达人的应助被xiang采纳,获得10
5秒前
wzy完成签到,获得积分10
6秒前
科目三的应助被明前易拉罐采纳,获得10
6秒前
MADAO发布了新的文献求助30
6秒前
7秒前
嗷嗷ao发布了新的文献求助10
7秒前
简单的浩然关注了科研通微信公众号
7秒前
哈哈嘿完成签到,获得积分10
8秒前
9秒前
千凡发布了新的文献求助10
10秒前
异乡人发布了新的文献求助10
10秒前
四月完成签到,获得积分10
10秒前
调皮的醉山完成签到 ,获得积分10
10秒前
10秒前
9527发布了新的文献求助10
11秒前
LL关闭了LL的文献求助
11秒前
一切顺利完成签到,获得积分10
12秒前
MARIO完成签到 ,获得积分10
12秒前
Chemistry完成签到,获得积分10
12秒前
chensiying完成签到 ,获得积分10
13秒前
13秒前
13秒前
Arya发布了新的文献求助10
13秒前
调皮钧发布了新的文献求助10
13秒前
13秒前
15秒前
CodeCraft的应助被rose采纳,获得10
15秒前
领导范儿的应助被嗷嗷ao采纳,获得10
16秒前
crystal完成签到,获得积分10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181839
求助须知:如何正确求助?哪些是违规求助? 9571584
关于积分的说明 21818707
捐赠科研通 7778124
什么是DOI,文献DOI怎么找? 3433524
关于科研通互助平台的介绍 2557710
邀请新用户注册赠送积分活动 2479621